Inosine, calcium channels, and neuroprotection against ischemic brain injury.
Tsuda
Kazushi
K
D000109:Acetylcholine / Q000378:metabolism; D058918:Adenosine A3 Receptor Antagonists; D000818:Animals; D001921:Brain / Q000473:pathology; D002545:Brain Ischemia / Q000209:etiology / Q000517:prevention & control*; D015220:Calcium Channels / Q000378:metabolism*; D002490:Central Nervous System / Q000187:drug effects; D004095:Dihydropyridines / Q000494:pharmacology; D016291:Dizocilpine Maleate / Q000494:pharmacology; D004594:Electrophysiology; D007288:Inosine / Q000008:administration & dosage / Q000494:pharmacology*; D007511:Ischemia; D018696:Neuroprotective Agents / Q000494:pharmacology; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors
D058918:Adenosine A3 Receptor Antagonists; D015220:Calcium Channels; D004095:Dihydropyridines; C107728:MRS 1191; D018696:Neuroprotective Agents; D016194:Receptors, N-Methyl-D-Aspartate; D007288:Inosine; D016291:Dizocilpine Maleate; D000109:Acetylcholine